With a ferritin of 26 ng/mL, low‑normal serum iron, high total iron‑binding capacity, low transferrin saturation, and elevated unsaturated iron‑binding capacity, what is the diagnosis and recommended next steps for evaluation and treatment?

Iron Deficiency Anemia Confirmed – Initiate Treatment and Evaluate for Gastrointestinal Blood Loss

With a ferritin of 26 ng/mL, low-normal serum iron, high TIBC, low transferrin saturation, and elevated UIBC, you have confirmed iron deficiency anemia and should immediately start oral iron supplementation while pursuing bidirectional endoscopy to identify the source of blood loss. 1, 2

Diagnosis

Your laboratory pattern is diagnostic of iron deficiency anemia:

• Ferritin 26 ng/mL is well below the diagnostic threshold of <45 ng/mL (85% sensitivity, 92% specificity for iron deficiency) 1
• Low transferrin saturation with high TIBC and elevated UIBC confirms depleted iron stores with inadequate iron availability for erythropoiesis
• This constellation eliminates anemia of chronic disease, where ferritin would be normal-to-elevated and TIBC would be low

The 2020 AGA guideline established ferritin <45 ng/mL as the optimal threshold, balancing sensitivity (85%) against specificity (92%) to minimize missed diagnoses while avoiding excessive false positives 1. Your ferritin of 26 ng/mL provides high diagnostic certainty without need for additional confirmatory testing.

Immediate Next Steps

1. Start Oral Iron Replacement Now

Begin ferrous sulfate 325 mg (65 mg elemental iron) every other day on an empty stomach 2, 3:

• Every-other-day dosing improves absorption compared to daily dosing and reduces gastrointestinal side effects that cause 50% of patients to discontinue therapy 3
• Take 1 hour before meals or 2 hours after meals for optimal absorption
• If not tolerated on empty stomach, take with meals (preferably with meat protein and 500 mg vitamin C to enhance absorption) 2
• Alternative formulations (ferrous fumarate, ferrous gluconate, ferrous bisglycinate) may be better tolerated if ferrous sulfate causes intolerable side effects, though no formulation has proven superior 2

Reassess response in 2-4 weeks with complete blood count and reticulocyte count 3:

• Expected reticulocyte response within 1-2 weeks
• Hemoglobin should increase by 1-2 g/dL within 3-4 weeks
• If inadequate response or intolerance, switch to intravenous iron

2. Pursue Gastrointestinal Evaluation

Schedule bidirectional endoscopy (EGD and colonoscopy) at the same session 1:

This is a strong recommendation from the 2020 AGA guideline for all asymptomatic postmenopausal women and men with iron deficiency anemia 1. The recommendation assumes:

• No other unequivocal explanation exists after thorough evaluation
• Patient is asymptomatic (symptomatic patients require symptom-directed evaluation)

Before endoscopy, obtain:

• Noninvasive testing for Helicobacter pylori (stool antigen or urea breath test) – common cause of iron deficiency anemia 2, 3
• Celiac disease serologies (tissue transglutaminase IgA with total IgA) – another common cause of malabsorption-related iron deficiency 2, 3

3. Evaluate Alternative Causes

Obtain detailed history focusing on:

• Menstrual history in premenopausal women (heavy menstrual bleeding accounts for significant iron loss)
• Dietary assessment: vegetarian/vegan diet, inadequate dietary iron intake
• Medication review: NSAIDs, anticoagulants, antiplatelet agents causing occult GI bleeding
• Blood donation history: frequent blood donors can develop iron deficiency
• Non-GI blood loss: hematuria, epistaxis, hemoptysis

Common Pitfalls to Avoid

1. Do not delay iron replacement while awaiting endoscopy – treatment and evaluation should proceed simultaneously 2

2. Do not use ferritin <15 ng/mL as your diagnostic threshold – this older cutoff has only 59% sensitivity and will miss 41% of iron-deficient patients 1

3. Do not order transferrin saturation or soluble transferrin receptor in straightforward cases – your ferritin of 26 ng/mL is diagnostic; these tests are reserved for patients with inflammatory conditions where ferritin may be falsely elevated (ferritin 45-100 ng/mL with concurrent inflammation) 1, 2

4. Do not assume dietary deficiency alone in postmenopausal women or men – 94% of cases result from recurrent blood loss, making GI evaluation mandatory 3

5. Do not give daily iron dosing – alternate-day dosing improves absorption and tolerability 2, 3

Treatment Targets

• Hemoglobin: normalize to 12-13 g/dL in women, 13-14 g/dL in men
• Ferritin: replete to >100 ng/mL to restore iron stores 4
• Continue iron for 3-6 months after hemoglobin normalizes to fully replenish body iron stores

When to Use Intravenous Iron

Switch to IV iron if 2, 3:

• Intolerance to oral iron despite formulation changes
• Inadequate response after 4-6 weeks of oral therapy
• Malabsorption syndromes (celiac disease, inflammatory bowel disease)
• Ongoing blood loss exceeding oral replacement capacity
• Patient has heart failure (IV iron improves exercise capacity and outcomes)

Modern IV iron formulations (ferric carboxymaltose, iron sucrose, ferumoxytol) have hypersensitivity rates <1% 3.